Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Liposarcoma × pemigatinib × Clear all

Sponsor

Conditions

Acrocephalosyndactylia 5 Cholangiocarcinoma 3 Carcinoma, Transitional Cell 3 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Stomach Neoplasms 1 Recurrence 1 Oligodendroglioma 1 Neoplasms, Unknown Primary 1 Multiple Myeloma 1 Lung Neoplasms 1 Glioma 1 Glioblastoma 1 Eosinophilia 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Advanced Malignancies 1

Interventions

Doxorubicin 6 pazopanib 5 Trabectedin 4 Radiotherapy 3 temsirolimus 2 eribulin 2 Sunitinib 2 Radiotherapy, Conformal 2 Ifosfamide 2 Dexamethasone 2 sitravatinib 1 selinexor 1 saracatinib 1 romidepsin 1 regorafenib 1 plitidepsin 1 pembrolizumab 1 palbociclib 1 olaratumab 1 milademetan 1 liposomal doxorubicin 1 lenvatinib 1 indolepropanol phosphate 1 efatutazone 1 cixutumumab 1 brigimadlin 1 avelumab 1 atezolizumab 1 Watchful Waiting 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡